XML 32 R2.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2025
Sep. 30, 2024
Sep. 30, 2023
Current assets      
Cash $ 193,263 $ 557,823 $ 98,106
Prepaid expenses 10,424 19,286 12,760
Deferred offering costs 161,806 139,017
Total current assets 365,493 716,126 110,866
Property and equipment, net 2,268 3,315 5,409
TOTAL ASSETS 367,761 719,441 116,275
Current liabilities      
Payables and accrued liabilities 151,573 31,332 140,400
Tax payable 5,298  
Due to related parties 391,597 191,952 27,233
Payable related to acquisition of non-controlling interest   218,267
Loan payable 20,516  
Deferred revenue 395,077 380,077 403,440
Total current liabilities 964,061 603,361 789,340
TOTAL LIABILITIES 964,061 603,361 789,340
Commitments and Contingencies
STOCKHOLDERS’ EQUITY (DEFICIT)      
Common stock, $0.001 par value, 50,000,000 and 50,000,000 shares authorized, 10,031,273 and 7,986,112 shares issued and outstanding at September 30, 2024 and 2023, respectively 10,031 [1] 10,031 [1],[2] 7,986 [2]
Additional paid-in capital 2,162,945 2,162,945 436,409
Accumulated deficit (2,769,276) (2,056,896) (1,117,460)
Total stockholders’ equity (deficit) (596,300) 116,080 (673,065)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 367,761 $ 719,441 $ 116,275
[1] Shares and per share data are presented on a retroactive basis to reflect the reorganization and the 1.2-for-1 reverse stock split.
[2] Shares and per share data are presented on a retroactive basis to reflect the reorganization and the 1.2-for-1 reverse stock split.